Effects of palmitoyl CoA and palmitoyl carnitine on the membrane potential and Mg2+ content of rat heart mitochondria

• Published in: Molecular and cellular biochemistry Vol. 116; no. 1-2; pp. 117 - 123
• Main Authors: Siliprandi, D, Biban, C, Testa, S, Toninello, A, Siliprandi, N
• Format: Journal Article
• Language: English
• Published: Netherlands 21-10-1992
• Subjects: Animals; Calcium - pharmacology; Cell Membrane - drug effects; Cyclosporine - pharmacology; Magnesium - metabolism; Magnesium - pharmacology; Membrane Potentials - drug effects; Mitochondria, Heart - drug effects; Mitochondria, Heart - metabolism; Palmitoyl Coenzyme A - pharmacology; Palmitoylcarnitine - pharmacology; Rats; Ruthenium Red - pharmacology
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/bf01270578

Palmitoyl CoA and palmitoyl carnitine added to rat heart mitochondria in amounts above 20 and 50 nmoles/mg protein, respectively, induced a fall in transmembrane potential and loss of endogenous Mg2+. The dissipation of membrane potential by low concentrations of palmitoyl CoA in the presence of Ca2+, but not that of high concentrations of palmitoyl CoA alone, was prevented by either ruthenium red, Cyclosporin A or Mg2+, but reversed only by Mg2+. The fall of membrane potential induced by palmitoyl carnitine was not prevented by any of these factors. It is suggested that the action of both palmitoyl CoA and palmitoyl carnitine at high concentrations is due to a non specific disruption of membrane architecture, while that of low concentrations of palmitoyl CoA in the presence of Ca2+ is associated specifically with energy dissipation due to Ca2+ cycling.